Latest IDERA Release Offers the Industry's Most Complete View of AWS Infrastructure

HOUSTON--(BUSINESS WIRE)--
IDERA, a leading provider of database lifecycle management solutions, today announced the newest release of Uptime Cloud Monitor. The updated product integrates 16 new AWS services, bringing the total to 22 and making Uptime Cloud Monitor the most comprehensive view of AWS services and infrastructure in the market.

This Smart News Release features multimedia. View the full release here: 

With AWS representing nearly 30 percent of the cloud infrastructure services market share, there is a growing need for more in-depth monitoring of AWS services. IDERA Uptime Cloud Monitor integrates with Amazon CloudWatch for AWS and enhances its capabilities through faster troubleshooting, long-term data storage and a comprehensive user interface.
Prior to this release, Uptime Cloud Monitor covered Billing Information, Elasticache, DynamoDB, Elastic Book Store, Elastic Cloud Compute and Relational Database Service, with the latter two ranking among the top six most-used AWS services, according to recent usage data. Four others in the top six include Simple Storage Service, Simple Queue Service, Route 53 DNS and Simple Notification Service, and are among the 16 newly added services that ensure as users grow and diversify their AWS footprint, Uptime Cloud Monitor grows with them.
“Since many of our customers use AWS to power their infrastructures, integrating more AWS metrics into our existing monitoring capabilities adds value and visibility for users,” said Beth Chauvin, product manager at IDERA. “Uptime Cloud Monitor is the ideal solution for a hybrid environment, including on premises servers and others hosted in the cloud. If someone is transitioning part of their server environment to the cloud, they can have critical AWS metrics at their disposal. Plus, our on-demand pricing allows customers to only pay for what they use, providing extensive monitoring benefits without enterprise-level costs.”
With the installation of Uptime Cloud Monitor’s lightweight agents, data can be collected more frequently, enabling users to perform real-time troubleshooting as errors and issues arise. Uptime Cloud Monitor can display, alert and store AWS metrics for up to one year, allowing for true historical trending. The updated product also offers a unified custom dashboard that is easy to navigate, allowing users to view 22 AWS services at-a-glance without switching to other applications.
“Uptime Cloud Monitor is a great AWS monitoring tool. No other monitoring software is able to accomplish what the IDERA solution can do,” said David Moore, operations manager at OneCloud Systems.


About IDERA
IDERA understands that IT doesn’t run on the network – it runs on the data and databases that power your business. That’s why we design our products with the database as the nucleus of your IT universe. Our database lifecycle management solutions allow database and IT professionals to design, develop, secure, monitor and improve data systems with complete confidence, whether in the cloud or on-premises. Serving more than 20,000 customers worldwide, we offer a diverse portfolio of free tools and educational resources to help you do more with less while giving you the knowledge to deliver even more than you did yesterday.

Read More

Pent up dollar demand by jewellers to exert pressure on rupee: Experts

Mumbai, March 26 (IANS) Pent up demand for US dollars by the jewellery sector, coupled with a weak Chinese yuan, are expected to exert pressure on the Indian rupee during the upcoming week, experts said on Saturday.
"Keep an eye out for the bullion users, as once they get back to work, we can see a lot of pent up demand from these guys to emerge. This demand, along with demand from central bank can exert an upward pressure on dollar/rupee (pair)," Anindya Banerjee, associate vice president for currency derivatives with Kotak Securities, told IANS.
A sizeable section of jewellery industry players have been on strike against a proposed one percent hike in excise duty on non-silver jewellery in the union budget for 2016-17.
They have been on strike since March 2. The central government has constituted a panel to look into their demands.
"Chinese yuan has begun weakening which should be an added negative for rupee as well. We see USD/INR trade between 66.30-50 and 67.00/67-20 levels for the next week," Banerjee cited.
According to Banerjee, despite a mid-week sell-off towards 66.93, rupee managed to close nearly flat, due to relentless selling of US dollars from fronts like IT (information technology) companies.
"Demand for US dollars from RBI (Reserve Bank of India) has managed to build a floor under the US dollar for the moment, around 66.40-50 levels on spot," Banerjee elaborated.
"However going into the final quarter of the year, we can see more selling from large exporters."
During the truncated week ended March 23, the rupee weakened by 12 paise. The domestic currency markets were closed on Thursday-Friday, on account of Holi and Good Friday.
On a weekly basis, the rupee weakened by 12 paise to 66.62-63 (March 23) against a US dollar from its previous close of 66.50-51 (March 18) to a greenback.
Other analysts, attributed the rupee weakness on a strong US dollar. The US dollar has strengthened on the back of increased chances of a hike in US interest rates in April.
Even the Brussels attacks led investors to park their funds in safe assets like the US dollar.
Anand James, co-head, technical research desk with Geojit BNP Paribas Financial Services, told IANS: "The US dollar rose due to its appeal as a safe haven asset, pushing rupee towards the 67 mark."
However, there was an increased inflows by the foreign investors in the country's equity and bond markets.
The National Securities Depository Limited (NSDL) figures showed that the FPIs (Foreign Portfolio Investors) bought Rs.6,340.82 crore or $952.79 million in the equity and debt markets from March 21-23.
Data with stock exchanges disclosed that the FPIs invested in stocks worth Rs.3,468.68 crore during the week under review.
According to Hiren Sharma, senior vice president, currency advisory at Anand Rathi Financial Services, US Federal Reserve's slow rate vision and expansion of ECB's (European Central Bank) bond purchase program has motivated global equity investors.
"A revival in crude oil price has instigated a risk on mood presently. Since March 1st, a net of $1.6 billion inflow (mostly in equity) has come into India," Sharma told IANS.
"Rupee has a very strong support at 66.50-40 and resistance around 66.80-67.10. It is expected to remain in this range for penultimate week of FY15-16."

Read More

Shutdown observed in Himachal against excise duty on jewellery

Shimla, March 26 (IANS) Shops and commercial establishments were shut in nearly all towns of Himachal on Saturday, as traders protested against the union budgetary proposal to impose one percent excise duty on non-silver jewellery.
There was, however, no report of violence anywhere, a police official said.
The city's business hub The Mall wore a deserted look with shopkeepers joining the All-India strike by the trading community to protest against the excise duty.
However, eateries and shops selling essential items were exempted from the shut down.

Likewise, shops in prominent towns like Solan, Dharamsala, Kangra, Palampur, Mandi, Kullu, Manali, Una and Hamirpur remained partially closed for the day.

Read More

Immunetics BacTx® Test Helps Hospitals Meet FDA Proposed Changes in Platelet Bacteria Testing Practices

Immunetics today announced that the FDA has published updated Draft Guidance for Industry - “Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion”. The proposed changes by the FDA in platelet bacteria testing practices cited the risks of bacterial contamination of platelets and the critical need for means to mitigate these risks. Immunetics BacTx^® Technology provides hospitals with a rapid, low cost, and proven solution to meet this new guidance.
The point-of-issue BacTx^® test allows hospitals to readily facilitate efficient testing of platelets with a rapid testing system for bacterial detection that meets the proposed FDA Guidance. The result is a safer platelet supply, providing transfusion services with a “last look” at the platelet unit just prior to transfusion.
Platelets are associated with a higher risk of sepsis and related fatalities than any other transfusable blood component. In the United States today, blood collection facilities must adhere to AABB Guidelines calling for every platelet to be tested using an FDA approved device. However, the risk of bacterial infection persists- the primary issue being sampling error, as most testing occurs early in the life of the platelet unit when bacteria counts may be too low to be captured during routine sampling. In the updated March 2016 Guidance document, the FDA indicates the need to improve the safety of platelet transfusions by secondary bacterial testing, and confirms that use of a rapid assay such as the BacTx^® test closer to the point of transfusion may mitigate these risks.

About Immunetics:
Immunetics Inc. offers state-of-the-art assay technology for infectious disease diagnosis and blood screening, and for more than ten years has been a leading innovator of tests for bacterial, viral, and parasitic diseases. Immunetics is headquartered in Boston. The company’s mission is to deliver better, cost-efficient care through more accurate diagnosis.

Read More